ZEVRA THERAPEUTICS, INC. — Director's Dealing 2021

Aug 18, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: KEMPHARM, INC (KMPH)
CIK: 0001434647
Period of Report: 2021-08-18

Reporting Person: SEYMOUR TAMARA A (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$9.2200	2031-08-17	Common Stock (22500)		Direct

Footnotes

F1: Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the "Plan"). 33.33% of the total shares subject to the option vest in equal annual installments beginning on August 18, 2022 through August 18, 2024, provided that at the relevant vesting dates such optionee's directorial relationship has not been terminated as defined in and as determined under the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer. The option expires ten years after the date of grant.